Skip to main content
SpringerLink
Log in

The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems

  • Original Paper
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

To elucidate the cellular distribution of osteopontin (OPN) in normal human tissues, we undertook immunohistochemistry using two site-specific OPN antibodies. The 10A16 monoclonal antibody was raised against the amino acid sequence just downstream of the thrombin cleavage site, while the O-17 polyclonal antibody was raised against the N-terminal peptide. Each antibody has been confirmed previously to react with both whole OPN and its relevant fragments. The expression pattern for these two antibodies was similar in distribution. In addition, we also identified expression in Ebner’s gland, type II pneumocytes, Kupffer cells, cells of the endocrine organs, anterior lens capsule and ciliary body, synovial type A cells, mesothelia, adipocytes, and mast cells. Neurons and glia in the central nervous system and spinal cord, cranial and peripheral nerve sheaths, ganglion cells in the sympathetic ganglion, intestinal plexuses, retina, and choroid plexus also regularly exhibited OPN positivity. Testicular germ cells, pancreatic exocrine cells, and follicular dendritic cells reacted with 10A16 only, whereas lutein cells and taste bud cells exhibited O-17 reactivity alone. These minor differences were hypothesized to reflect the state of OPN in the cells; that is, whether OPN was in its whole molecule or fragmented form. In conclusion, we demonstrate that OPN is widely distributed in normal human cells, particularly those comprising the central and peripheral nervous systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280:460–465

    Article  PubMed  CAS  Google Scholar 

  2. Hamada Y, Yuki K, Okazaki M, Fujitani W, Matsumoto T, Hashida MK, Harutsugu K, Nokihara K, Daito M, Matsuura N, Takahashi J (2004) Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo. Dent Mater J 23:650–655

    PubMed  CAS  Google Scholar 

  3. Wai PY, Kuo PC (2004) The role of osteopontin in tumor metastasis. J Surg Res 121:228–241

    Article  PubMed  CAS  Google Scholar 

  4. Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16:79–87

    Article  PubMed  CAS  Google Scholar 

  5. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302–2309

    Article  PubMed  CAS  Google Scholar 

  6. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Cell Biol 3: 1169–1180

    CAS  Google Scholar 

  7. Qu-Hong, Brown LF, Senger DR, Geng LL, Dvorak HF, Dvorak AM (1994) Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells. J Histochem Cytochem 42:351–361

    PubMed  CAS  Google Scholar 

  8. Qu-Hong, Brown LF, Dvorak HF, Dvorak AM (1997) Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J Histochem Cytochem 45:21–33

    PubMed  CAS  Google Scholar 

  9. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, Lessey BA (2001) Osteopontin and its receptor alpha(v)beta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 86:4991–5000

    Article  PubMed  CAS  Google Scholar 

  10. Arafat HA, Wein AJ, Chacko S (2002) Osteopontin gene expression and immunolocalization in the rabbit urinary tract. J Urol 167:746–752

    Article  PubMed  CAS  Google Scholar 

  11. Ogbureke KU, Fisher LW (2004) Expression of SIBLINGs and their partner MMPs in salivary glands. J Dent Res 83:664–670

    Article  PubMed  CAS  Google Scholar 

  12. de Silva Rudland S, Martin L, Roshanlall C, Winstanley J, Leinster S, Platt-Higgins A, Carroll J, West C, Barraclough R, Rudland P (2006) Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 12:1192–1200

    Article  PubMed  CAS  Google Scholar 

  13. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262:2900–2907

    PubMed  CAS  Google Scholar 

  14. Sørensen S, Justesen SJ, Johnsen AH (2003) Purification and characterization of osteopontin from human milk. Protein Expr Purif 30:238–245

    Article  PubMed  CAS  Google Scholar 

  15. Kon S, Maeda M, Segawa T, Hagiwara Y, Horikoshi Y, Chikuma S, Tanaka K, Rashid MM, Inobe M, Chambers AF, Uede T (2000) Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J Cell Biochem 77:487–498

    Article  PubMed  CAS  Google Scholar 

  16. Butler WT (1989) The nature and significance of osteopontin. Connect Tissue Res 23:123–136

    Article  PubMed  CAS  Google Scholar 

  17. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (1990) cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7:491–502

    Article  PubMed  CAS  Google Scholar 

  18. von Wolff M, Bohlmann MK, Fiedler C, Ursel S, Strowitzki T (2004) Osteopontin is up-regulated in human decidual stromal cells. Fertil Steril 81(suppl 1):741–748

    Google Scholar 

  19. Briese J, Schulte HM, Bamberger CM, Löning T, Bamberger AM (2006) Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Int J Gynecol Pathol 25:161–169

    Article  PubMed  Google Scholar 

  20. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145:610–623

    PubMed  CAS  Google Scholar 

  21. Daiter E, Omigbodun A, Wang S, Walinsky D, Strauss JF III, Hoyer JR, Coutifaris C (1996) Cell differentiation and endogenous cyclic adenosine 3′,5′-monophosphate regulate osteopontin expression in human trophoblasts. Endocrinology 137:1785–1790

    Article  PubMed  CAS  Google Scholar 

  22. Gabinskaya T, Salafia CM, Gulle VE, Holzman IR, Weintraub AS (1998) Gestational age-dependent extravillous cytotrophoblast osteopontin immunolocalization differentiates between normal and preeclamptic pregnancies. Am J Reprod Immunol 40:339–461

    PubMed  CAS  Google Scholar 

  23. Johnson GA, Burghardt RC, Bazer FW, Spencer TE (2003) Osteopontin: roles in implantation and placentation. Biol Reprod 69:1458–1471

    Article  PubMed  CAS  Google Scholar 

  24. Briese J, Oberndörfer M, Pätschenik C, Schulte HM, Makrigiannakis A, Löning T, Bamberger AM (2005) Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. J Clin Endocrinol Metab 90:5407–5413

    Article  PubMed  CAS  Google Scholar 

  25. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ (2004) Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10:184–190

    Article  PubMed  CAS  Google Scholar 

  26. Ogbureke KU, Fisher LW (2005) Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 68:155–166

    Article  PubMed  CAS  Google Scholar 

  27. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645–1657

    Article  PubMed  CAS  Google Scholar 

  28. Forootan SS, Foster CS, Aachi VR, Adamson J, Smith PH, Lin K, Ke Y (2006) Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 118:2255–2261

    Article  PubMed  CAS  Google Scholar 

  29. Ogbureke KU, Fisher LW (2007) SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity. J Histochem Cytochem 55:403–409

    Article  PubMed  CAS  Google Scholar 

  30. Chang P-L, Harkins L, Hsieh Y-H, Hicks P, Sappayatosok K, Yodsanga S, Swasdison S, Chambers AF, Elmets CA, Ho K-J (2008) Osteopontin expression in normal skin and non-melanoma skin tumors. J Histochem Cytochem 56:57–66

    Article  PubMed  CAS  Google Scholar 

  31. Ehrchen J, Heuer H, Sigmund R, Schäfer MK, Bauer K (2001) Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary. J Endocrinol 169:87–96

    Article  PubMed  CAS  Google Scholar 

  32. Fierabracci A, Biro PA, Yiangou Y, Mennuni C, Luzzago A, Ludvigsson J, Cortese R, Bottazzo GF (1999) Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. Vaccine 18:342–354

    Article  PubMed  CAS  Google Scholar 

  33. Wang Y, Mochida S, Kawashima R, Inao M, Matsui A, YouLuTuZ Y, Nagoshi S, Uede T, Fujiwara K (2000) Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. J Gastroenterol 35:696–701

    Article  PubMed  CAS  Google Scholar 

  34. Kawashima R, Mochida S, Matsui A, YouLuTuZ Y, Ishikawa K, Toshima K, Yamanobe F, Inao M, Ikeda H, Ohno A, Nagoshi S, Uede T, Fujiwara K (1999) Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256:527–531

    Article  PubMed  CAS  Google Scholar 

  35. Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S (2008) Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 38:489–499

    Article  PubMed  CAS  Google Scholar 

  36. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA (1995) Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem 270:28471–28478

    Article  PubMed  CAS  Google Scholar 

  37. Omigbodun A, Ziolkiewicz P, Tessler C, Hoyer JR, Contifaris C (1997) Progesterone regulates osteopontin expression in human trophoblasts: a model of paracrine control in the placenta? Endocrinology 138:4308–4315

    Article  PubMed  CAS  Google Scholar 

  38. Yamazaki K, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, Takano K, Obara T, Sato K (2003) Genes regulated by thyrotropin and iodide in cultured human thyroid follicles: analysis by cDNA microarray. Thyroid 13:149–158

    Article  PubMed  CAS  Google Scholar 

  39. Nakamura M, Oka M, Iizuka N, Kawauchi S, Gondo T, Ueno T, Tongoku A (2002) Osteopontin expression in chronic pancreatitis. Pancreas 25:182–187

    Article  PubMed  Google Scholar 

  40. Viganò P, Lattuada D, Mangioni S, Ermellino L, Vignail M, Caporizzo E, Panina-Bordignon P, Besozzi M, DiBlasio AM (2006) Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 36:415–424

    Article  PubMed  CAS  Google Scholar 

  41. Sodhi CP, Phadke SA, Batlle D, Sahai A (2001) Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50:1482–1490

    Article  PubMed  CAS  Google Scholar 

  42. Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F, Wollert-Wulf B, Fleck E, Graf K (2002) Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 4:139–146

    Article  PubMed  CAS  Google Scholar 

  43. Iczkiewicz J, Jackson MJ, Smith RA, Roses S, Jenner P (2006) Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson’s disease. Brain Res 1118:239–250

    Article  PubMed  CAS  Google Scholar 

  44. Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C (2007) Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol Dis 25:473–482

    Article  PubMed  CAS  Google Scholar 

  45. Jander S, Bussini S, Neuen-Jacob E, Bosse F, Menge T, Müller HW, Stoll G (2002) Osteopontin: a novel axon-regulated Schwann cell gene. J Neurosci Res 67:156–166

    Article  PubMed  CAS  Google Scholar 

  46. Kim MD, Cho HJ, Shin T (2004) Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 151:78–84

    Article  PubMed  CAS  Google Scholar 

  47. Ju WK, Kim KY, Cha JH, Kim IB, Lee MY, Oh SJ, Chung JW, Chun MH (2000) Ganglion cells of the rat retina show osteopontinlike immunoreactivity. Brain Res 852:217–220

    Article  PubMed  CAS  Google Scholar 

  48. Chidlow G, Wood JP, Manavis J, Osborne NN, Casson RJ (2008) Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci 49:762–771

    Article  PubMed  Google Scholar 

  49. Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS (2007) Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer’s disease brain. Curr Alzheimer Res 4:67–72

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan

    Yasuto Kunii & Toshimitsu Suzuki

  2. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan

    Yasuto Kunii & Shin-ichi Niwa

  3. Immunobiological Laboratories, Takasaki, Japan

    Yoshiaki Hagiwara, Masahiro Maeda & Tsutomu Seitoh

Authors
  1. Yasuto Kunii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shin-ichi Niwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiaki Hagiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahiro Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tsutomu Seitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshimitsu Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kunii, Y., Niwa, Si., Hagiwara, Y. et al. The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems. Med Mol Morphol 42, 155–161 (2009). https://doi.org/10.1007/s00795-009-0459-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-009-0459-6

Key words

Search

Navigation